Amgen
Search results
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
- Responsibility
The CoLab, previously the Biogen Community Lab, is a...
- Alzheimer's Disease
Biogen’s commitment to health equity is rooted in efforts...
- Amyotrophic Lateral Sclerosis
Kate was busy planning her wedding when she was diagnosed...
- Lupus
Biogen’s decades of study at the crossroads of neurology and...
- Multiple Sclerosis
Multiple sclerosis (MS) is a complex, heterogeneous, chronic...
- Spinal Muscular Atrophy
SMA, an inherited disease that can have a devastating effect...
- Pipeline
With a strong focus on difficult-to-treat diseases, our...
- News Releases
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb)...
- Responsibility
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan ...
Jan 31, 2024 · Biogen will focus on LEQEMBI® (lecanemab-irmb) with Eisai and advancing potential new modalities to address the multiple pathologies of the disease and unmet patient needs. A plan for patients participating in clinical trials or on commercially available treatment is in place.
Biogen is a global biotechnology company that develops innovative medicines for various diseases, including rare and neurological disorders. Follow its LinkedIn page to see its latest news, updates, events, and collaborations in the field of biotechnology research.
Biogen is a global company that discovers, develops and delivers innovative therapies for neurological and neurodegenerative diseases. Founded in 1978, Biogen has a leading portfolio of medicines for multiple sclerosis, spinal muscular atrophy and other neuroscience fields.
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose pf serving humanity through science while ...
